MARLYN ESCALONA: Open Payments
NPI 1285213793 · SPRING VALLEY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,102 in 40 payments from 14 companies in 2025. Trend: 2023 $1,062 · 2024 $1,421 · 2025 $1,102
Food & beverage: $1,102
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $244 |
| E.R. Squibb & Sons, L.L.C. | 12 | $158 |
| Insulet Corporation | 1 | $140 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $140 |
| Merck Sharp & Dohme LLC | 7 | $111 |
| Novartis Pharmaceuticals Corporation | 5 | $105 |
| Neurocrine BioSciences, Inc. | 4 | $70 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| Dexcom, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $21 |
Products named: Omnipod, Kerendia, CAMZYOS, Ozempic, VERQUVO, LEQVIO, INGREZZA, ELIQUIS.
Industry payments across NY — which companies pay providers there.
